Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant condition of multiple myeloma with few known risk factors. The emergence of mass spectrometry (MS) for the detection of MGUS has provided new opportunities to evaluate its risk factors. In total, 2628 individuals at elevated...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | angličtina |
Vydáno: |
2024
|
On-line přístup: | https://doi.org/10.1182/bloodadvances.2023010843 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|